Stock listing
NASDAQ:GLMD Galmed Pharmaceuticals Ltd. Stock
Home listing (NASDAQ) of Galmed Pharmaceuticals Ltd.
Follow Galmed Pharmaceuticals Ltd. into a list and get an email when it puts out news.
Share price · NASDAQ:GLMD
$3.22 USD +0.02 (+0.6%)
Close on Oct 29, 2026 · Data provided by Twelve Data
- Day range
- $3.16 – $3.48 USDOct 29, 2026
- Volume
- 6,744 sharesOct 29, 2026
- Market cap
- $403,060 USDAt the close on Oct 29, 2026 · price × 125,174 shares outstanding
- 52-week range
- $0.411 – $5.45 USDLowest and highest trades, Oct 30, 2025 – Oct 29, 2026
- Traded on an average day
- $102,929 USDMedian day 10,180 shares · last 3 months, Jul 29, 2026 – Oct 29, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GLMD · Home | $3.22 USD | +0.02 (+0.6%) | 6,744 | $3.17 | $3.479 | $3.16 | $3.20 | Close on Oct 29, 2026 |
Daily closes
Last 3 months, Jul 29, 2026 – Oct 29, 2026 · NASDAQ:GLMD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.22 | +0.02 | +0.6% | $3.17 | $3.479 | $3.16 | 6,744 | |
| $3.20 | +0.12 | +3.9% | $3.17 | $3.31 | $3.00 | 7,384 | |
| $3.08 | -0.07 | -2.2% | $3.062 | $3.19 | $3.062 | 2,091 | |
| $3.15 | +0.12 | +4.0% | $3.10 | $3.28 | $3.10 | 3,578 | |
| $3.03 | -0.045 | -1.5% | $3.11 | $3.27 | $2.96 | 8,767 | |
| $3.075 | -0.044 | -1.4% | $3.04 | $3.10 | $2.96 | 7,146 | |
| $3.119 | +0.049 | +1.6% | $2.97 | $3.12 | $2.90 | 7,059 | |
| $3.07 | +0.22 | +7.7% | $2.865 | $3.07 | $2.82 | 6,620 | |
| $2.85 | 0.00 | 0.0% | $3.035 | $3.082 | $2.81 | 7,839 | |
| $2.85 | -0.20 | -6.6% | $2.91 | $3.09 | $2.33 | 10,989 | |
| $3.05 | +0.04 | +1.3% | $2.92 | $3.159 | $2.92 | 1,972 | |
| $3.01 | -0.155 | -4.9% | $3.13 | $3.13 | $2.67 | 9,822 | |
| $3.165 | -0.055 | -1.7% | $3.23 | $3.37 | $3.10 | 9,144 | |
| $3.22 | -0.32 | -9.0% | $3.41 | $3.41 | $3.22 | 9,476 | |
| $3.54 | -0.08 | -2.2% | $3.46 | $3.60 | $3.46 | 5,975 | |
| $3.62 | +0.162 | +4.7% | $3.61 | $3.63 | $3.42 | 14,797 | |
| $3.458 | +0.098 | +2.9% | $3.49 | $3.63 | $3.35 | 13,527 | |
| $3.36 | -0.09 | -2.6% | $3.45 | $3.563 | $3.28 | 10,180 | |
| $3.45 | -0.16 | -4.4% | $3.55 | $3.62 | $3.45 | 7,671 | |
| $3.61 | +0.205 | +6.0% | $3.326 | $3.62 | $3.26 | 4,850 | |
| $3.405 | -0.085 | -2.4% | $3.14 | $3.62 | $3.12 | 12,577 | |
| $3.49 | -0.06 | -1.7% | $3.45 | $3.49 | $3.39 | 2,602 | |
| $3.55 | -0.08 | -2.2% | $3.595 | $3.63 | $3.50 | 5,635 | |
| $3.63 | 0.00 | 0.0% | $3.46 | $3.63 | $3.46 | 3,889 | |
| $3.63 | +0.01 | +0.3% | $3.62 | $3.80 | $3.56 | 3,682 | |
| $3.62 | 0.00 | 0.0% | $3.752 | $3.752 | $3.62 | 2,963 | |
| $3.62 | -0.005 | -0.1% | $3.47 | $3.65 | $3.46 | 5,356 | |
| $3.625 | +0.125 | +3.6% | $3.65 | $3.80 | $3.45 | 15,767 | |
| $3.50 | +0.13 | +3.9% | $3.33 | $3.66 | $3.33 | 3,493 | |
| $3.37 | -0.11 | -3.2% | $3.47 | $3.60 | $3.346 | 8,492 | |
| $3.48 | +0.07 | +2.1% | $3.48 | $3.92 | $3.267 | 14,190 | |
| $3.41 | -0.215 | -5.9% | $3.50 | $3.65 | $3.39 | 10,562 | |
| $3.625 | -0.195 | -5.1% | $3.58 | $3.75 | $3.50 | 14,002 | |
| $3.82 | -0.02 | -0.5% | $3.72 | $3.89 | $3.503 | 10,607 | |
| $3.84 | -0.19 | -4.7% | $4.00 | $4.221 | $3.655 | 44,886 | |
| $4.03 | -0.60 | -13.0% | $4.28 | $4.88 | $3.89 | 192,001 | |
| $4.63 | +0.805 | +21.0% | $3.91 | $4.63 | $3.82 | 303,322 | |
| $3.825 | -0.055 | -1.4% | $3.81 | $3.96 | $3.74 | 14,800 | |
| $3.88 | -0.04 | -1.0% | $4.075 | $4.23 | $3.88 | 4,100 | |
| $3.92 | -0.199 | -4.8% | $4.05 | $4.062 | $3.90 | 12,100 | |
| $4.119 | +0.194 | +4.9% | $3.97 | $4.223 | $3.94 | 14,700 | |
| $3.925 | -0.195 | -4.7% | $4.07 | $4.12 | $3.818 | 24,000 | |
| $4.12 | -0.045 | -1.1% | $4.04 | $4.16 | $4.03 | 7,200 | |
| $4.165 | -0.141 | -3.3% | $4.16 | $4.26 | $3.959 | 5,400 | |
| $4.306 | -0.024 | -0.6% | $4.29 | $4.38 | $4.16 | 5,700 | |
| $4.33 | +0.025 | +0.6% | $4.28 | $4.40 | $4.22 | 4,500 | |
| $4.305 | +0.255 | +6.3% | $4.08 | $4.49 | $3.96 | 40,200 | |
| $4.05 | -0.255 | -5.9% | $4.11 | $4.13 | $3.679 | 48,300 | |
| $4.305 | -0.255 | -5.6% | $4.54 | $4.54 | $4.12 | 21,700 | |
| $4.56 | -0.21 | -4.4% | $4.56 | $4.80 | $4.22 | 107,500 | |
| $4.77 | +0.29 | +6.5% | $5.38 | $5.45 | $4.10 | 231,100 | |
| $4.48 | +0.376 | +9.2% | $4.208 | $4.624 | $4.16 | 36,913 | |
| $4.104 | -0.08 | -1.9% | $4.16 | $4.88 | $4.00 | 120,950 | |
| $4.184 | -0.064 | -1.5% | $4.16 | $4.248 | $4.08 | 5,688 | |
| $4.248 | -0.232 | -5.2% | $4.328 | $4.544 | $4.24 | 3,625 | |
| $4.48 | +0.024 | +0.5% | $4.456 | $4.656 | $4.24 | 14,600 | |
| $4.456 | +3.863 | +651.4% | $4.56 | $4.60 | $4.40 | 3,688 | |
| $0.593 | -0.009 | -1.5% | $0.598 | $0.60 | $0.581 | 14,400 | |
| $0.602 | +0.003 | +0.5% | $0.574 | $0.602 | $0.573 | 21,900 | |
| $0.599 | +0.019 | +3.3% | $0.57 | $0.60 | $0.56 | 13,300 | |
| $0.58 | +0.005 | +0.9% | $0.564 | $0.58 | $0.56 | 24,000 | |
| $0.575 | -0.01 | -1.7% | $0.57 | $0.576 | $0.56 | 44,200 | |
| $0.585 | -0.014 | -2.3% | $0.613 | $0.613 | $0.575 | 72,800 | |
| $0.599 | +0.039 | +7.0% | $0.541 | $0.599 | $0.53 | 108,000 | |
| $0.56 | +0.026 | +4.9% | $0.531 | $0.56 | $0.51 | 87,100 |
- Ticker
- NASDAQ:GLMD
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 9, 2026
Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation
Latest deck · Jun 8, 2026
Merger or Acquisition (June 2026)
Merger or acquisition · 14 slides
Calls
Replays
Galmed Pharmaceuticals (NASDAQ:GLMD) Q4 2021 Earnings Call
Mon, May 02, 2022 · 8:30 AM ET
Watch TranscriptGalmed Pharmaceuticals (NASDAQ:GLMD) Q3 2021 Earnings Call
Mon, Nov 08, 2021 · 8:30 AM ET
Watch TranscriptGalmed Pharmaceuticals (NASDAQ:GLMD) Q2 2021 Earnings Call
Thu, Aug 05, 2021 · 8:30 AM ET
Watch Transcript
Latest news
Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation
Sep 9, 2026
Closed $4.63 (+21.0%) on Sep 9, 2026
Galmed Announces Successful First-in-Human Proof-of-Concept Clinical Study Results for Colospan's Novel Intraoperative Tissue Assessment Technology
Aug 19, 2026
Closed $4.77 (+6.5%) on Aug 19, 2026
Galmed Announces First Time Results in Prostate Oncology Studies: Aramchol Demonstrates 3-4 Fold Increase in Cell Death Compared to Enzalutamide (XTANDI®) Alone in Prostate Cancer Models
Aug 17, 2026
Closed $4.10 (-1.9%) on Aug 17, 2026
Galmed Announces Breakthrough Development of Dispersible Film Delivery (ODF), Brain Penetrating formulation of its SCD1 inhibitor Aramchol for Parkinson's Disease, Targeting $6 Billion Market
Jul 28, 2026
Closed $0.534 (+1.3%) on Jul 28, 2026
Galmed Announces the Breakthrough Development of Novel LNP Cardiac Targeted Formulation of its SCD1 inhibitor, Aramchol
Jul 16, 2026
Closed $0.55 (+7.0%) on Jul 16, 2026
Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition
Jun 22, 2026
Closed $0.564 (-2.8%) on Jun 22, 2026
Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market
Jun 8, 2026
Closed $0.469 (-32.6%) on Jun 8, 2026
Tissue Dynamics and Galmed Unveil Unknown Metabolic Pathway for Cardiac Fibrosis and Heart Failure which Supports the Development of Aramchol for Cardiac Fibrosis
Jun 2, 2026
Closed $0.691 (-5.0%) on Jun 2, 2026
Financings
Ordinary shares
Sep 9, 2026
Cancelled: up to US$20M
Buyers: YA II PN, LTD. (Yorkville)
Decks
Merger or Acquisition (June 2026)
Merger or acquisition · 14 slides · Jun 8, 2026
Technical Presentation (November 2021)
Technical · 13 slides · Nov 8, 2021
Investor Day (January 2021)
Investor day · 42 slides · Jan 26, 2021
Investor Presentation (August 2020)
Investor deck · 24 slides · Aug 6, 2020
Galmed Pharmaceuticals Ltd. on 6ix
- News releases
- 20 in the last 12 months · 89 in all · newest Sep 9, 2026 · oldest 2019
- Calls
- 4 calls with a replay · 4 with a transcript · latest May 2, 2022
- Decks
- 7 decks · latest Jun 8, 2026
Where Galmed Pharmaceuticals Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GLMD · Home listing · This page | NASDAQ | United States | USD |
| BOATS:GLMD | BOATS | United States | USD |
| Frankfurt:GPH | Frankfurt | Germany | EUR |
| Lang & Schwarz:A1XFUX | Lang & Schwarz | Germany | EUR |
| LS Exchange:A1XFUX | LS Exchange | Germany | EUR |
Log in to ask 6ix AI your own questions about Galmed Pharmaceuticals Ltd.